Keywords: CMU-PAC; Chiang Mai University-Picture Archive Communication system; CT; Computed tomography (CT); ECOG; Eastern Cooperative Oncology Group; EGFR; Epidermal growth factor receptor; IARC; International Agency for Research on Cancer (IARC); ICD-O; Internati
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: A.F; Alexander Falk; ADT; Androgen Deprivation Therapy; AMSTAR; Assessing the Methodological Quality of Systematic Reviews; BED; Biological Effective Dose; b-PFS; Biochemical Progression-Free Survival; BT; Brachytherapy; CI; Confidence Interval; CONSORT;
Keywords: NACT; neoadjuvant chemotherapy; pCR; complete pathological response; HER2; human epidermalgrowth factor receptor-2; NCCN; National Comprehensive Cancer Network; LABC; locally advanced breast cancer; M&P; Miller&Payne; DCIS; ductal carcinoma in situ; ER; e
Keywords: Cancer cachexia; Clinical practice guidelines; CPG; AGREE; Quality; AGREE II; Appraisal of Guidelines for Research and Evaluation II; ICC; intraclass correlation coefficient; ASPEN; American Society for Parenteral and Enteral Nutrition; ESPEN; European So
Keywords: Differentiated thyroid carcinoma; Cervical lymph node; Metastasis; Neck lymph node dissection; Cáncer de tiroides diferenciado; Ganglio cervical; Metástasis; Disección de ganglios del cuello; DTC; differentiated thyroid carcinoma; LNM; lymph node metas
Keywords: 7â+â3; cytarabine 7 days and daunorubicin (3 days); AE; adverse event; alloHSCT; allogeneic hematopoietic stem cell transplant; AML; acute myeloid leukemia; AML-MRC; AML with myelodysplasia-related changes; AR; allelic ratio; BSC; best supportive care
Keywords: biopsy; curettage; metastasis; phototherapy; radiotherapy; squamous cell carcinoma; staging; surgery; surveillance; topical therapy; AAD; American Academy of Dermatology; AJCC; American Joint Committee on Cancer; BCC; basal cell carcinoma; BWH; Brigham an
Keywords: Immunoassay; Serum biomarker; Cancer; Follow-up; Prognosis; Histotype; HE4; human epididymis protein 4; OC; ovarian cancer; CA125; carbohydrate antigen 125; HR; hazard ratio; PFS; progression-free survival; NCCN; National Comprehensive Cancer Network; GCI
Keywords: Cladribine; Cytarabine; Idarubicin; Acute myeloid leukemia; Induction chemotherapy; Leukemia risk; NCCN; ELN; Anthracycline; Risk prediction; Prognosis; AML;
Keywords: ACOSOG; American College of Surgeons Oncology Group; AJCC; American Joint Committee on Cancer; CI; confidence interval; CoC; Commission on Cancer; IQR; interquartile range; NCCN; National Comprehensive Cancer Network; OR; odds ratio; UICC; Union for Inter
Keywords: ACCP; American College of Chest Physicians; CATS; Canadian Association of Thoracic Surgeons; CCO; Cancer Care Ontario; cIA; clinical stage IA; CT; computed tomography; EBUS; endobronchial ultrasound; EUS; endoscopic ultrasound; ESTS; European Society for
Keywords: Well-differentiated thyroid carcinoma; De-escalation; Thyroidectomy; American Thyroid Association; Guidelines; AACE; American Association of Clinical Endocrinologists; AAES; American Association of Endocrine Surgeons; ACE; American College of Endocrinolog
Keywords: prostatic neoplasms; biopsy; magnetic resonance imaging; genomics; pathology; ADC; apparent diffusion coefficient; AP; adverse pathology; GPSâ¢; Genomic Prostate Score; GS; Gleason score; mpMRI; multiparametric MRI; MRI; magnetic resonance imaging; NCCN;
Keywords: microRNA-331; Breast cancer; Breast benign tumors; Ductal adenocarcinoma; Lobular adenocarcinoma; Biomarker; ASCO; American Society of Clinical Oncologists; AUC; Area under the curve; CAP; College of American Pathologists; cDNA; Complementary DNA; DCIS; D
Keywords: PJS; Peutz-Jeghers Syndrome; GI; gastrointestinal; NCCN; National Comprehensive Cancer Network; NGS; Next Generation Sequencing; Peutz-Jeghers syndrome; Gastrointestinal polys; Mucocutaneous pigmentation; STK11 gene;
Keywords: Non-small cell lung cancer; Geriatric Nutritional Risk Index; Predictive and prognostic factor; AUC; area under the curve; BVI; blood vessel invasion; CEA; carcinoembryonic antigen; CS; cancer-specific survival; CT; computed tomography; CYFRA; cytokeratin
Keywords: acantholysis; acantholytic actinic keratosis; cutaneous oncology; dermatopathology; follicular squamous cell carcinoma; nonmelanoma skin cancer; outcomes; prognosis; squamous cell carcinoma; aAK; acantholytic actinic keratosis; AK; actinic keratosis; aSCC
Keywords: Breast cancer; Imaging; Overuse; Utilization; Surveillance; Staging; ASCO; American Society of Clinical Oncology; NCCN; National Comprehensive Cancer Network; ESMO; European Society of Medical Oncology; ESO; European School for Oncology; MBC; metastatic b
Keywords: appropriate use criteria; excision; invasive melanoma; Mohs micrographic surgery; subclinical spread; AJCC; American Joint Committee on Cancer; CI; confidence interval; NCCN; National Comprehensive Cancer Network; MART-1; melanoma antigen recognized by T
Keywords: atypical nevi; dermatopathology; dysplastic nevi; melanocytic lesions; melanoma; melanoma in situ; treatment; M-Path; Melanocytic Pathology Assessment Tool and Hierarchy; MPATH-Dx; Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis; NCCN; N
Keywords: cutaneous squamous cell carcinoma; staging; prognosis; radiologic imaging; disease-related outcomes; nodal metastasis; squamous cell carcinoma imaging; AJCC; American Joint Committee on Cancer; BWH; Brigham and Women's Hospital; CI; confidence interval; C
Keywords: AJCC; American Joint Committee on Cancer; HR; hazard ratio; LN; lymph node; NCCN; National Comprehensive Cancer Network; SEER; Surveillance, Epidemiology, and End Results;
Keywords: ABC; advanced breast cancer; CGH; comparative genomic hybridization; CNA; copy number alterations; CTC; circulating tumor cells; ctDNA; cell-free tumor DNA; DEP; dielectrophoretic; DFS; disease-free survival; dPCR; digital PCR; EBC; early breast cancer; E
Keywords: AJCC; American Joint Committee on Cancer; AUA; American Urological Association; CTU; Computed tomography urography; DWI; diffusion-weighted imaging; MIBC; muscle invasive bladder cancer; NCCN; National Comprehensive Cancer Network; NMIBC; non-muscle invas
Keywords: ATA; American Thyroid Association; CoC; Commission on Cancer; HR; hazard ratio; NCCN; National Comprehensive Cancer Network; NCDB; National Cancer Database; OR; odds ratio; PDAC; pancreatic ductal adenocarcinoma; PTC; papillary thyroid cancer;
Keywords: atypical carcinoid; lung NET; pulmonary neuroendocrine tumors; RADIANT-4; typical carcinoid; AC; atypical carcinoids; ENETS; European Neuroendocrine Tumor Society; LCNEC; large cell neuroendocrine carcinoma; NCCN; National Comprehensive Cancer Network; NE
Keywords: incomplete resection; lung cancer; postoperative therapy; survival; National Comprehensive Cancer Network (NCCN); adjuvant therapy; HR; hazard ratio; IQR; interquartile range; NCCN; National Comprehensive Cancer Network; NCDB; National Cancer Database; NS
Keywords: melanoma; melanoma management; surgical margins; biopsy; follow up; guidelines; primary cutaneous melanoma; AAD; American Academy of Dermatology; CI; confidence interval; MMIS; malignant melanoma in-situ; NCCN; National Comprehensive Cancer Network; OR; o
Keywords: HPV; human papillomavirus; EBV; Epstein-Barr virus; PCR; polymerase chain reaction; AOR; adjusted odds ratio; NCCN; National Comprehensive Cancer Network; Head and neck cancer; Pathology; Biostatistics; Historical cohort study; Oral cancer; Multivariate
Keywords: consensus; dermatopathology; discordance; melanoma; melanoma in situ; microstaging parameters; prognosis; second opinion; AJCC; American Joint Committee on Cancer; EUH; Emory University Hospital; NCCN; National Comprehensive Cancer Network; SLNB; sentinel
Keywords: Pca; prostate cancer; mpMRI; multiparametric magnetic resonance imaging; EBRT; external beam radiation therapy; DRE; digital rectal examination; TRUS; transrectal ultrasonography; PSA; prostate-specific antigen; GS; Gleason score; NCCN; National comprehen
Keywords: CR; complete response; CTLA-4; cytotoxic lymphocyte-associated antigen 4; ECOG; Eastern Cooperative Oncology Group; EORTC; European Organization for Research and Treatment of Cancer; GAP; Good Agricultural Practice; GMP; Good Manufacturing Practice; NCCN;
Keywords: aRR; adjusted risk ratio; AUC; area under the receiver operating curve; NCCN; National Comprehensive Cancer Network; NCDB; National Cancer Data Base; pCR; pathologic complete response;
Keywords: AUC; area under the curve; BVI; blood vessel invasion; CEA; carcino embryonic antigen; CT; computed tomography; CYFRA; cytokeratin 19 fragment; FDG-PET; fluorodeoxyglucose-positron emission tomography; LVI; lymphatic vessel invasion; MRI; magnetic resonan
Keywords: Ab; Antibody; ABC; ATP-binding cassette; AIOM; Associazione Italiana di Oncologia Medica; ALCAM; Activated leukocyte cell adhesion molecule; APOD; Apolipoprotein D; AR; androgen receptor; AURKA; Aurora kinase A; AURKB; Aurora kinase B; BCS; Biopharmaceuti
Keywords: ACR; American College of Radiology; CT; computed tomography; EBUS; endobronchial ultrasonography; LDCT; low-dose computed tomography; LungRADS; Lung Imaging Reporting and Data System; NCCN; National Comprehensive Cancer Network; NLST; National Lung Screen
Keywords: 5-FU; 5-fluorouracil; FDA; Food and Drug Administration; FISH; fluorescent in situ hybridization; GEJ; gastroesophageal junction; HER2; human epidermal growth factor receptor 2; IHC; immunohistochemistry; ISH; in situ hybridization; NBF; neutral buffered
Keywords: Socioeconomic status; NCCN; Ovary cancer; Adherent care;
Keywords: Hereditary Nonpolyposis Colorectal Cancer; HNPCC; Colon Cancer Genetics; Inherited Cancer; CI; confidence interval; CRC; colorectal cancer; EC; endometrial cancer; HBOC; hereditary breast/ovarian cancer; IHC; immunohistochemistry; LS; Lynch syndrome; MMR;
Keywords: urinary bladder; carcinoma; papillary; evidence-based practice; practice guideline; risk; AUA; American Urological Association; CIS; carcinoma in situ; CTU; computerized tomography urogram; EAU; European Association of Urology; ICUD; International Consult
Keywords: Cancer; Genomics; Next-generation sequencing; Report; Variant annotation; CAP; College of American Pathologists; COSMIC; Catalog of Somatic Mutations in Cancer; EMR; electronic medical records; MAF; mutant allele fraction; NCCN; National Comprehensive Can
Keywords: CAPP2; Colorectal/Adenoma/Carcinoma Prevention Programme; CL; confidence level; CRC; colorectal cancer; EC; endometrial cancer; FCRCTX; familial colorectal cancer type X; GRADE; Grades of Recommendation, Assessment, Development, and Evaluation; HNPCC; her
Keywords: Lynch Syndrome; Colorectal Cancer; Genetic Testing; CAPP2; Colorectal/Adenoma/Carcinoma Prevention Programme; CL; confidence level; CRC; colorectal cancer; EC; endometrial cancer; FCRCTX; familial colorectal cancer type X; GRADE; Grades of Recommendation,
Keywords: NCCN; National Comprehensive Cancer Network; NSCLC; non-small cell lung cancer; 4; 10;
Keywords: Submucosal tumour; Gastrointestinal stromal tumour; GIST; Incidental GIST; Guidelines; NCCN; Laparoscopic surgery; Mitosis; Risk stratification;
POINT: Should Lung Cancer Screening Be Expanded to Persons Who Don't Currently Meet Accepted Criteria Set Forth by the CHEST Guidelines on Lung Cancer Screening? Yes
Keywords: CHEST; American College of Chest Physicians; LDCT; low-dose CT; NCCN; National Comprehensive Cancer Network; NLST; National Lung Screening Trial;
Detection of KIT mutations in core binding factor acute myeloid leukemia
Keywords: CBF-AML; KIT mutations; FLT-3 mutations; HRM analysis; CBF-AML; core binding factor AML; PCR-RFLP; Polymerase chain reaction restriction fragment length polymorphism; HRM; High resolution melting curve analysis; NCCN; National comprehensive cancer network
Methodology for tissue sample collection within a translational sub-study of the CHHiP trial (CRUK/06/016), a large randomised phase III trial in localised prostate cancer
Keywords: BATS; Blood and Tissue Samples database; BIDD; Biomarker and Imaging Discovery and Development Committee; CHHiP; Conventional or Hypofractionated High dose intensity modulated radiotherapy in Prostate cancer; CRN; Clinical Research Network; CTU; Clinical
The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients
Keywords: BC; bladder cancer; NMIBC; non muscle invasive bladder cancer; MIBC; muscle invasive bladder cancer; EAU; European association of urology; EORTC; European Organisation for Research and Treatment of Cancer.; TUR; trans-urethral resection; BCG; Bacillus of
CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia
Keywords: ANC; Absolute neutrophil count; AML; Acute myeloid leukemia; BL; Baseline; BM; Bone marrow; CI; Confidence intervals; CMML; Chronic myelomonocytic leukemia; CR; Complete remission; ECOG; Eastern Cooperative Oncology Group; HI; Hematologic improvement; HI-